NCT05515588View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 690517 is Taken up and Handled by the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

November 17, 2022

Study Completion Date

November 17, 2022

Conditions
Healthy
Interventions
DRUG

BI 690517 (C-14)

BI 690517 (C-14)

DRUG

BI 690517

BI 690517

Trial Locations (1)

9728 NZ

ICON, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05515588 - A Study in Healthy Men to Test How BI 690517 is Taken up and Handled by the Body | Biotech Hunter | Biotech Hunter